Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ANEB on Nasdaq
Shares outstanding
41,587,315
Price per share
$0.85
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,741,386
Total reported value
$6,808,914
% of total 13F portfolios
0%
Share change
-11,077
Value change
-$68,403
Number of holders
16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
English Aron R. 51% 0% $25,877,258 21,929,880 0% Aron R. English 24 Feb 2025
Nantahala Capital Management, LLC 8.5% -1.1% $3,582,872 3,547,398 0% Nantahala Capital Management, LLC 31 Dec 2025
MANGROVE PARTNERS IM, LLC 6.2% $2,979,797 2,525,252 Mangrove Partners IM, LLC 31 Dec 2024

As of 31 Dec 2025, 16 institutional investors reported holding 6,741,386 shares of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB). This represents 16% of the company’s total 41,587,315 outstanding shares.

Top 21 Institutional Shareholders

The largest institutional shareholders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) together control 53% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 7.3% 3,036,325 0% 0.18% $3,066,688
MANGROVE PARTNERS IM, LLC 6.1% 2,525,252 0% 0.21% $2,550,505
VANGUARD GROUP INC 1% 435,821 +42% 0% $440,179
MORGAN STANLEY 0.96% 399,404 0% 0% $403,398
GEODE CAPITAL MANAGEMENT, LLC 0.39% 160,760 -7.7% 0% $162,482
Rangeley Capital, LLC 0.12% 50,000 +150% 0.04% $50,500
RENAISSANCE TECHNOLOGIES LLC 0.06% 25,098 -12% 0% $25,349
CITADEL ADVISORS LLC 0.06% 24,239 0% $24,481
BlackRock, Inc. 0.06% 23,790 -1.1% 0% $24,028
NORTHERN TRUST CORP 0.05% 21,994 -9.8% 0% $22,214
Ikarian Capital, LLC 0.04% 17,736 -89% 0% $17,913
STATE STREET CORP 0.03% 12,768 0% 0% $12,896
Tower Research Capital LLC (TRC) 0.01% 3,230 +85% 0% $3,262
UBS Group AG 0.01% 2,334 +961% 0% $2,357
JPMORGAN CHASE & CO 0.01% 2,253 +5.4% 0% $2,276
BANK OF AMERICA CORP /DE/ 0% 382 -57% 0% $386
BARCLAYS PLC 0% 0 -100% $0
BOOTHBAY FUND MANAGEMENT, LLC 0% 0 -100% $0
CITIGROUP INC 0% 0 -100% $0
XTX Topco Ltd 0% 0 -100% $0
22NW, LP 37% 15,467,300 0% $84,760,804

Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,741,386 $6,808,914 -$68,403 $1.01 16
2025 Q3 22,219,763 $55,549,711 -$356,433 $2.50 20
2025 Q2 22,591,946 $32,532,431 -$34,513 $1.44 18
2025 Q1 22,618,242 $29,403,638 +$39,506 $1.30 18
2024 Q4 22,570,347 $37,311,560 +$24,974,043 $1.68 15
2024 Q3 7,343,734 $14,173,448 +$69,135 $1.93 13
2024 Q2 7,307,778 $19,950,292 +$326 $2.73 12
2024 Q1 7,306,365 $20,969,328 +$85,916 $2.87 14
2023 Q4 7,278,993 $17,615,165 +$183,945 $2.42 13
2023 Q3 7,050,491 $21,560,562 +$51,779 $3.06 11
2023 Q2 7,031,883 $16,498,373 +$460,020 $2.35 11
2023 Q1 6,836,130 $19,834,339 -$508,787 $2.90 9
2022 Q4 7,046,307 $17,074,708 -$15,992 $2.42 12
2022 Q3 6,842,912 $19,161,000 +$6,062,684 $2.80 10
2022 Q2 4,677,847 $24,324,000 +$2,192,344 $5.20 8
2022 Q1 4,190,412 $29,539,000 -$21,602 $7.02 8
2021 Q4 4,193,307 $25,818,000 +$61,833 $6.21 8
2021 Q3 4,183,214 $27,472,000 -$109,295 $6.58 7
2021 Q2 4,199,813 $28,670,000 +$28,670,000 $6.85 8